论文部分内容阅读
目的:探讨氨溴索治疗小儿支原体肺炎的临床效果。方法:收治支原体肺炎患儿80例,随机分成观察组和对照组。对照组采用常规治疗加阿奇霉素,观察组在对照组基础上加用氨溴索注射液,比较两组治疗效果。结果:在观察组,退热时间、咳喘消失时间、肺部啰音消失时间、肺部炎症消失时间、用力肺活量、第一秒最大呼气量、最大呼气流速、用力呼气25%流速、用力呼气50%流速均显著优于对照组(P<0.05)。结论:氨溴索治疗小儿支原体肺炎效果显著。
Objective: To investigate the clinical efficacy of ambroxol in treating children with mycoplasma pneumonia. Methods: 80 cases of children with mycoplasma pneumonia were randomly divided into observation group and control group. The control group received routine treatment plus azithromycin. The observation group was given ambroxol injection on the basis of the control group, and the therapeutic effect was compared between the two groups. Results: The observation group, antipyretic time, cough disappear time, pulmonary rales disappear time, lung inflammation disappear time, forced vital capacity, the first second maximum expiratory volume, maximum expiratory flow, forced expiratory flow 25% , 50% forced expiratory flow rate were significantly better than the control group (P <0.05). Conclusion: Ambroxol is effective in treating children with mycoplasmal pneumonia.